We are live on ! Find out more
NVNO

enVVeno Medical

26 hedge funds and large institutions have $17.3M invested in enVVeno Medical in 2024 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 8 increasing their positions, 7 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

4,229% more call options, than puts

Call options by funds: $1.65M | Put options by funds: $38K

14% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 7

0.08% less ownership

Funds ownership: 0.78%0.71% (-0.08%)

13% less capital invested

Capital invested by funds: $19.8M → $17.3M (-$2.55M)

16% less funds holding

Funds holding: 3126 (-5)

50% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 8

Holders
26
Holders Change
-5
Holders Change %
-16.13%
% of All Funds
0.38%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
8
Reduced
7
Closed
8
Calls
$1.65M
Puts
$38K
Net Calls
+$1.61M
Net Calls Change
-$2.3M
Name Holding Trade Value Shares
Change
Change in
Stake
Bank of America
26
Bank of America
North Carolina
$520 +$524 +3 New
VCIM
27
Velan Capital Investment Management
Georgia
-$937K -4,921 Closed
Marshall Wace
28
Marshall Wace
United Kingdom
-$218K -1,146 Closed
Janney Montgomery Scott
29
Janney Montgomery Scott
Pennsylvania
-$186K -975 Closed
Jane Street
30
Jane Street
New York
-$138K -723 Closed
Squarepoint
31
Squarepoint
New York
-$122K -640 Closed
QC
32
Quadrature Capital
United Kingdom
-$103K -539 Closed
HF
33
HRT Financial
New York
-$75K -396 Closed
Acadian Asset Management
34
Acadian Asset Management
Massachusetts
-$37K -195 Closed

NVNO Hedge Fund Activity: Q2 2024 in Review

26 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in enVVeno Medical (NVNO) for Q2 2024, worth a combined $17.3M — down 13% from $19.8M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of NVNO and 4 opened new positions — a net loss of 4 holders — while 7 trimmed existing stakes and 8 added.

The largest buyer was Westside Investment Management, adding an estimated $175K. The largest seller was Velan Capital Investment Management, exiting entirely with an estimated $937K sold.

  • 26 institutional investors held enVVeno Medical (NVNO) as of Q2 2024, down from 31 in Q1 2024.
  • Funds reported $17.3M of enVVeno Medical stock for Q2 2024, down 13% quarter-over-quarter.
  • 4 funds opened new enVVeno Medical positions in Q2 2024 and 8 closed out, a net change of -4 holders.
  • The largest enVVeno Medical buyer in Q2 2024 was Westside Investment Management, an estimated $175K added.
  • The largest enVVeno Medical seller in Q2 2024 was Velan Capital Investment Management, an estimated $937K sold.

Based on aggregated 13F filings for Q2 2024.